No Data
Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), PTC Therapeutics (PTCT) and Vir Biotechnology (VIR)
Insider Sale: President & CEO of $CYTK (CYTK) Sells 5,000 Shares
Cytokinetics to Participate in December Investor Conferences
JMP Securities Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $78
Optimistic Outlook for Cytokinetics Amidst Promising Aficamten Developments and Regulatory Progress
Needham Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $72